Scientific Founder, SAB Chairman Inventor Founding Core Faculty Member, Synthetic Biology Platform Lead, Wyss Institute for Biologically Inspired Engineering at Harvard University Professor of Genetics, Harvard Medical School Professor of Health Sciences and Technology, Harvard and MIT
George Church is a renowned geneticist at the forefront of genomic breakthroughs including next generation, DNA sequencing, and CRISPR. George is a scientific founder of ReadCoor and Chairman of the Scientific Advisory Board. He and his team initiated FISSEQ (Fluorescent In-Situ Sequencing) in 1999 and developed it at the Wyss Institute for Biologically Inspired Engineering and Harvard Medical School.
More About George
George leads the Wyss Institute’s Synthetic Biology Platform, where he oversees the directed evolution of molecules, polymers, and whole genomes to create new tools with applications in regenerative medicine and bioenergy. In 1984, he developed the first direct genomic sequencing method, which resulted in the first genome sequence (the human pathogen, H. pylori). He helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005.
George invented the broadly applied concepts of molecular multiplexing and tags, homologous recombination methods, and array DNA synthesizers. His many innovations have been the basis for a number of companies including AbVitro (now Juno), Editas Medicine, Veritas Genetics, Warpdrive Bio, Egenesis (transplantation) and ReadCoor (panomic spatial sequencing).
George is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Technology Center since 1987 and Director of the National Institutes of Health Center of Excellence in Genomic Science since 2004. He is member of the National Academy of Sciences and Engineering and has received the 2011 Bower Award and Prize for Achievement in Science from the Franklin Institute, and the 2009 Promega Biotechnology Research Award from the American Society for Microbiology. George received the Scripps Genomic Medicine award in 2016, and the following year was named to TIME’s list of 100 Most Influential People. George received his B.A. in Zoology and Chemistry from Duke University and a Ph.D. in Biochemistry and Molecular Biology from Harvard University.